Overexpression of p16INK4a in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection

Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, <etal>et al</etal>.. (2012) Epidemiology and Risk Factors of Urothelial Bladder Cancer. Eur Urol.

M Burger, 2013, ICUD-EAU International Consultation on Bladder Cancer 2012: Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, Eur Urol, 63, 36, 10.1016/j.eururo.2012.08.061

PL Ho, 2012, Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer, Cancer Res, 72, 3135, 10.1158/0008-5472.CAN-11-3195

T Beothe, 2012, P53 mutation and LOH at chromosome 9 in urothelial carcinoma, Anticancer Res, 32, 523

PA Kenney, 2011, Novel ZEB1 expression in bladder tumorigenesis, BJU Int, 107, 656, 10.1111/j.1464-410X.2010.09489.x

S Blanco, 2010, Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients, J Transl Med, 8, 122, 10.1186/1479-5876-8-122

J Oliva Encina, 2012, Words of wisdom. Re: Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder, Eur Urol, 61, 847, 10.1016/j.eururo.2012.01.033

MB Amin, 2013, ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology, Eur Urol, 63, 16, 10.1016/j.eururo.2012.09.063

AM Kamat, 2013, ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers, Eur Urol, 63, 4, 10.1016/j.eururo.2012.09.057

H Rayess, 2012, Cellular senescence and tumor suppressor gene p16, Int J Cancer, 130, 1715, 10.1002/ijc.27316

M Yin, 2008, p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ, Hum Pathol, 39, 527, 10.1016/j.humpath.2007.08.005

M von Knebel Doeberitz, 2012, Biomarkers for cervical cancer screening: the role of p16(INK4a) to highlight transforming HPV infections, Expert Rev Proteomics, 9, 149, 10.1586/epr.12.13

M Reuschenbach, 2008, Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers, Int J Cancer, 123, 2626, 10.1002/ijc.23837

J Polesel, 2012, Urinary human polyomavirus and papillomavirus infection and bladder cancer risk, Br J Cancer, 106, 222, 10.1038/bjc.2011.519

RE Alexander, 2012, p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma, Mod Pathol, 25, 1526, 10.1038/modpathol.2012.103

S Aggarwal, 2009, Koilocytosis: correlations with high-risk HPV and its comparison on tissue sections and cytology, urothelial carcinoma, Diagn Cytopathol, 37, 174, 10.1002/dc.20978

K Steinestel, 2012, Expression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis, PLoS One, 7, e40671, 10.1371/journal.pone.0040671

M Monticone, 2008, Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context, Mol Cancer, 7, 92, 10.1186/1476-4598-7-92

S Liebau, 2011, An SK3 channel/nWASP/Abi-1 complex is involved in early neurogenesis, PLoS One, 6, e18148, 10.1371/journal.pone.0018148

S Roperto, 2010, Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle, PLoS One, 5, e10299, 10.1371/journal.pone.0010299

S Roperto, 2012, Productive infection of bovine papillomavirus type 2 in the placenta of pregnant cows affected with urinary bladder tumors, PLoS One, 7, e33569, 10.1371/journal.pone.0033569

A Edgecombe, 2012, Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia, Appl Immunohistochem Mol Morphol, 20, 264, 10.1097/PAI.0b013e3182351ed3

K Cuschieri, 2008, Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia, Cancer Epidemiol Biomarkers Prev, 17, 2536, 10.1158/1055-9965.EPI-08-0306

JT Keating, 2001, Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia, Am J Surg Pathol, 25, 884, 10.1097/00000478-200107000-00006

M Nasioutziki, 2011, The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples, Int J Gynecol Cancer, 21, 79, 10.1097/IGC.0b013e3182009eea

K Shigehara, 2011, Etiologic role of human papillomavirus infection in bladder carcinoma, Cancer, 117, 2067, 10.1002/cncr.25777

K Shigehara, 2011, Etiological role of human papillomavirus infection for inverted papilloma of the bladder, J Med Virol, 83, 277, 10.1002/jmv.21966

KW Chan, 1997, Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction, J Clin Pathol, 50, 1018, 10.1136/jcp.50.12.1018

VE Gould, 2010, Human papillomavirus and p16 expression in inverted papillomas of the urinary bladder, Cancer Lett, 292, 171, 10.1016/j.canlet.2009.11.022

Shaker OG, Hammam OA, Wishahi MM (2012) Is there a correlation between HPV and urinary bladder carcinoma? Biomed Pharmacother.

L Cheng, 2010, The origins of urothelial carcinoma, Expert Rev Anticancer Ther, 10, 865, 10.1586/era.10.73

KB Hodges, 2010, Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features, Hum Pathol, 41, 155, 10.1016/j.humpath.2009.07.002

D Yavuzer, 2011, Role of human papillomavirus in the development of urothelial carcinoma, Med Oncol, 28, 919, 10.1007/s12032-010-9540-1

W Ben Selma, 2010, Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients, Pathol Res Pract, 206, 740, 10.1016/j.prp.2010.06.005

GM Volgareva, 2004, [Expression of p16INK4a in various cancer cells], Arkh Patol, 66, 3

GM Volgareva, 2010, Cellular expression of INK4a gene in cells of bladder cancer associated with human papilloma virus-16, Bull Exp Biol Med, 149, 242, 10.1007/s10517-010-0917-0

M Shuto, 2012, Significant Correlation between Chromosomal Aberration and Nuclear Morphology in Urothelial Carcinoma, Acta Histochem Cytochem, 45, 25, 10.1267/ahc.11048

C Romagosa, 2011, p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors, Oncogene, 30, 2087, 10.1038/onc.2010.614

HJ Yoo, 2012, DAPk1 inhibits NF-kappaB activation through TNF-alpha and INF-gamma-induced apoptosis, Cell Signal, 24, 1471, 10.1016/j.cellsig.2012.03.010

T Ogawa, 2010, CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis, J Urol, 183, 1206, 10.1016/j.juro.2009.11.007

J Yang, 2008, Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis, Dev Cell, 14, 818, 10.1016/j.devcel.2008.05.009

JK McKenney, 2001, Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion, Am J Surg Pathol, 25, 356, 10.1097/00000478-200103000-00010

M Davies, 2012, Transforming growth factor-beta enhances invasion and metastasis in Ras-transfected human malignant epidermal keratinocytes, Int J Exp Pathol, 93, 148, 10.1111/j.1365-2613.2011.00806.x

M Genua, 2012, Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells, PLoS One, 7, e40148, 10.1371/journal.pone.0040148

AC Hepburn, 2012, Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling, PLoS One, 7, e50690, 10.1371/journal.pone.0050690

YL Chen, 2011, Sorafenib inhibits transforming growth factor beta1-mediated epithelial-mesenchymal transition and apoptosis in mouse hepatocytes, Hepatology, 53, 1708, 10.1002/hep.24254

RD Lester, 2007, uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells, J Cell Biol, 178, 425, 10.1083/jcb.200701092

T Watabe, 1998, The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor, Int J Cancer, 77, 128, 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9